Differential modulations of striatal tyrosine hydroxylase and dopamine metabolism by cannabinoid agonists as evidence for functional selectivity in vivo-Reference-Cited by-同舟云学术

Differential modulations of striatal tyrosine hydroxylase and dopamine metabolism by cannabinoid agonists as evidence for functional selectivity in vivo

Published:2012-06 Issue:7 Volume:62 Page:2328-2336
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Bosier Barbara,Muccioli Giulio G.,Mertens Birgit,Sarre Sophie,Michotte Yvette,Lambert Didier M.,Hermans Emmanuel

Funder

Fonds Spéciaux de Recherche

Fonds De La Recherche Scientifique - FNRS

Université Catholique de Louvain

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference50 articles.

1. Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids;Andre;Eur. J. Neurosci.,2010

2. Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses;Bonhaus;J. Pharmacol. Exp. Ther.,1998

3. Changes in tyrosine hydroxylase gene expression in mesencephalic catecholaminergic neurons of immature and adult male rats perinatally exposed to cannabinoids;Bonnin;Brain Res. Dev. Brain Res.,1994

4. Differential modulation of AP-1- and CRE-driven transcription by cannabinoid agonists emphasizes functional selectivity at the CB1 receptor;Bosier;Br. J. Pharmacol.,2008

5. Concomitant activation of adenylyl cyclase suppresses the opposite influences of CB(1) cannabinoid receptor agonists on tyrosine hydroxylase expression;Bosier;Biochem. Pharmacol.,2009

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effects of Chronic Marijuana Administration on 6-OHDA-Induced Learning & Memory Impairment and Hippocampal Dopamine and Cannabinoid Receptors Interaction in Male Rats;Neurochemical Research;2023-03-09

2. CB1 agonism on mesolimbic and nigrostriatal dopaminergic neurotransmission;Neurobiology and Physiology of the Endocannabinoid System;2023

3. The Medial Prefrontal Cortex (mPFC) and Addictions;Handbook of Substance Misuse and Addictions;2022

4. The Medial Prefrontal Cortex (mPFC) and Addictions;Handbook of Substance Misuse and Addictions;2022

5. New perspectives on the role of the neurosteroid pregnenolone as an endogenous regulator of type‐1 cannabinoid receptor (CB1R) activity and function;Journal of Neuroendocrinology;2021-09-06